A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease

P (Hemachandra) Reddy

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

The purpose of this mini-forum, "Neurotransmitters and Alzheimer's Disease", is to critically assess the current status of neurotransmitters in Alzheimer's disease. Neurotransmitters are essential neurochemicals that maintain synaptic and cognitive functions in mammals, including humans, by sending signals across pre- to post-synaptic neurons. Authorities in the fields of synapses and neurotransmitters of Alzheimer's disease summarize the current status of basic biology of synapses and neurotransmitters, and also update the current status of clinical trials of neurotransmitters in Alzheimer's disease. This article discusses the prevalence, economic impact, and stages of Alzheimer's dementia in humans.

Original languageEnglish (US)
Pages (from-to)969-974
Number of pages6
JournalJournal of Alzheimer's Disease
Volume57
Issue number4
DOIs
StatePublished - 2017
Externally publishedYes

Fingerprint

Neurotransmitter Agents
Alzheimer Disease
Research
Synapses
Cognition
Mammals
Economics
Clinical Trials
Neurons

Keywords

  • Amyloid-β
  • cognitive decline
  • mitochondrial dysfunction
  • synaptic pathology

ASJC Scopus subject areas

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease. / Reddy, P (Hemachandra).

In: Journal of Alzheimer's Disease, Vol. 57, No. 4, 2017, p. 969-974.

Research output: Contribution to journalReview article

@article{54c513b2638e49f8b9e4a6bc331e15a2,
title = "A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease",
abstract = "The purpose of this mini-forum, {"}Neurotransmitters and Alzheimer's Disease{"}, is to critically assess the current status of neurotransmitters in Alzheimer's disease. Neurotransmitters are essential neurochemicals that maintain synaptic and cognitive functions in mammals, including humans, by sending signals across pre- to post-synaptic neurons. Authorities in the fields of synapses and neurotransmitters of Alzheimer's disease summarize the current status of basic biology of synapses and neurotransmitters, and also update the current status of clinical trials of neurotransmitters in Alzheimer's disease. This article discusses the prevalence, economic impact, and stages of Alzheimer's dementia in humans.",
keywords = "Amyloid-β, cognitive decline, mitochondrial dysfunction, synaptic pathology",
author = "Reddy, {P (Hemachandra)}",
year = "2017",
doi = "10.3233/JAD-170256",
language = "English (US)",
volume = "57",
pages = "969--974",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease

AU - Reddy, P (Hemachandra)

PY - 2017

Y1 - 2017

N2 - The purpose of this mini-forum, "Neurotransmitters and Alzheimer's Disease", is to critically assess the current status of neurotransmitters in Alzheimer's disease. Neurotransmitters are essential neurochemicals that maintain synaptic and cognitive functions in mammals, including humans, by sending signals across pre- to post-synaptic neurons. Authorities in the fields of synapses and neurotransmitters of Alzheimer's disease summarize the current status of basic biology of synapses and neurotransmitters, and also update the current status of clinical trials of neurotransmitters in Alzheimer's disease. This article discusses the prevalence, economic impact, and stages of Alzheimer's dementia in humans.

AB - The purpose of this mini-forum, "Neurotransmitters and Alzheimer's Disease", is to critically assess the current status of neurotransmitters in Alzheimer's disease. Neurotransmitters are essential neurochemicals that maintain synaptic and cognitive functions in mammals, including humans, by sending signals across pre- to post-synaptic neurons. Authorities in the fields of synapses and neurotransmitters of Alzheimer's disease summarize the current status of basic biology of synapses and neurotransmitters, and also update the current status of clinical trials of neurotransmitters in Alzheimer's disease. This article discusses the prevalence, economic impact, and stages of Alzheimer's dementia in humans.

KW - Amyloid-β

KW - cognitive decline

KW - mitochondrial dysfunction

KW - synaptic pathology

UR - http://www.scopus.com/inward/record.url?scp=85018759885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018759885&partnerID=8YFLogxK

U2 - 10.3233/JAD-170256

DO - 10.3233/JAD-170256

M3 - Review article

VL - 57

SP - 969

EP - 974

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -